Stockreport

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Vor Biopharma Inc.  (VOR) 
PDF BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announ [Read more]